Cargando…
Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019
IMPORTANCE: Glucagonlike peptide-1 receptor agonists (GLP-1RA), sodium-glucose cotransporter-2 inhibitors (SGLT2i), and dipeptidyl peptidase-4 inhibitors (DPP-4i) are associated with low rates of hypoglycemia, and postmarketing trials of GLP-1RA and SGLT2i demonstrated that these medications improve...
Autores principales: | McCoy, Rozalina G., Van Houten, Holly K., Deng, Yihong, Mandic, Pinar Karaca, Ross, Joseph S., Montori, Victor M., Shah, Nilay D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851726/ https://www.ncbi.nlm.nih.gov/pubmed/33523188 http://dx.doi.org/10.1001/jamanetworkopen.2020.35792 |
Ejemplares similares
-
Trends in Testosterone Prescriptions for Older Men Enrolled in Commercial Insurance and Medicare Advantage
por: Everhart, Alexander, et al.
Publicado: (2021) -
HbA(1c) overtesting and overtreatment among US adults with controlled type 2 diabetes, 2001-13: observational population based study
por: McCoy, Rozalina G, et al.
Publicado: (2015) -
Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study
por: Jeffery, Molly Moore, et al.
Publicado: (2018) -
Medicare and Private Insurance Variations in New Medical Technology: The Case of Drug Eluting Stents
por: Bayindir, Esra Eren, et al.
Publicado: (2016) -
Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage
por: Barsky, Benjamin A., et al.
Publicado: (2022)